CAS: 2131803-90-0
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
WYC-209 REF: AN-AG01JX4PCAS: 2131803-90-0 | 98% | To inquire | Tue 21 May 24 | |
WYC-209 REF: TM-T5341CAS: 2131803-90-0 | 98.91% | 59.00 €~452.00 € | Tue 28 May 24 | |
WYC-209 REF: 3D-GKD80390CAS: 2131803-90-0 | Min. 95% | To inquire | Tue 02 Jul 24 |
Ref: AN-AG01JX4P
5mg | 157.00 € | |
10mg | 248.00 € | |
25mg | 486.00 € | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
WYC-209
CAS:2131803-90-0
WYC-209 inhibits proliferation of malignant murine melanoma tumor-repopulating cells (TRCs, IC50: 0.19 uM). It targets …
Formula:
C20H20N2O3S
Purity:
98.91%
Color and Shape:
Solid
Molecular weight:
368.45
- Inhibitors
- Apoptosis
- Metabolism
- Retinoid Receptor
- See more categories
- Autophagy
Ref: TM-T5341
5mg | 59.00 € | |
10mg | 96.00 € | |
25mg | 177.00 € | |
50mg | 278.00 € | |
100mg | 452.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
WYC-209
CAS:2131803-90-0
WYC-209 is a synthetic compound that has the potential to be an effective cancer therapy. …
Formula:
C20H20N2O3S
Purity:
Min. 95%
Molecular weight:
368.45 g/mol
Ref: 3D-GKD80390
1mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Tuesday 2 Jul 2024